| RCL |
Report |
2Q26 Adjusted EPS |
BEAT |
pred ~$4.00 vs. cons $3.95 |
MEDIUM |
| RCL |
Report |
2Q26 Revenue |
IN-LINE |
pred ~$4.85B vs. cons $4.82B |
MEDIUM |
| RCL |
Report |
2Q26 Constant-Currency Net Yield Growth |
BEAT |
pred ~0.6% vs. cons 0.3% |
MEDIUM |
| RCL |
Guide |
FY26 Adjusted EPS Guidance |
LOWER |
guide ~$16.85 vs. cons $17.55 (FY26) |
MEDIUM |
| RCL |
Guide |
FY26 Constant-Currency Net Yield Growth Guidance |
LOWER |
guide ~1.0% vs. cons 2.0% (FY26) |
MEDIUM |
| RCL |
Guide |
3Q26 Adjusted EPS Guidance |
LOWER |
guide ~$4.45 vs. cons $4.70 (3Q26) |
MEDIUM |
| RCL |
Return |
Day-1 residual (stock − beta × S&P 500) |
-7.5% |
— |
MEDIUM |
| RCL |
Return |
5-day cumulative residual |
-10.0% (FOLLOW-THROUGH) |
A 2Q beat of ~$4.00 vs. $3.95 is outweighed by FY26 EPS guidance of ~$16.85 vs. $17.55 consensus and FY26 yield growth of ~1.0% vs. 2.0% consensus; out-period estimate cuts should extend the initial negative reaction. |
MEDIUM |